XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 95,266 $ 97,401
Accounts receivable, net of allowance for credit losses 125,764 136,142
Financing receivables, net of allowance for credit losses 125,450 129,384
Variable consideration receivables, net of allowance for credit losses 57,340 44,024
Inventories 37,291 31,534
Prepaid expenses 12,349 12,343
Film assets, net of accumulated amortization 8,162 5,277
Property, plant and equipment, net of accumulated depreciation 238,973 252,896
Investment in equity securities 1,046 1,035
Other assets 15,914 15,665
Deferred income tax assets, net of valuation allowance 11,450 9,900
Goodwill 52,815 52,815
Other intangible assets, net of accumulated amortization 33,886 32,738
Total assets 815,706 821,154
Liabilities    
Accounts payable 24,092 25,237
Accrued and other liabilities 116,658 117,286
Deferred revenue 67,715 70,940
Revolving credit facility borrowings, net of unamortized debt issuance costs 28,002 36,111
Convertible Notes and other borrowings, net of unamortized discounts and debt issuance costs 228,039 226,912
Deferred income tax liabilities 13,587 14,900
Total liabilities 478,093 491,386
Commitments, contingencies and guarantees (see Note 7)
Non-controlling interests    
Non-controlling interests 732 722
Shareholders' equity    
Capital stock common shares - no par value. Authorized - unlimited number. 54,620,083 issued and outstanding (December 31, 2022 - 54,148,614 issued and outstanding) 390,238 376,715
Other equity 175,374 185,678
Statutory surplus reserve 3,932 3,932
Accumulated deficit (284,208) (293,124)
Accumulated other comprehensive loss (14,622) (9,846)
Total shareholders' equity attributable to common shareholders 270,714 263,355
Non-controlling interests 66,167 65,691
Total shareholders' equity 336,881 329,046
Total liabilities and shareholders' equity $ 815,706 $ 821,154